Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 48,872 shares at $3.06 ($150K) on 2024-07-30, disclosed to the SEC on 2024-08-01.
Open-market purchase of $150k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.06 | 21,646 | $66K | 44.0% |
| 2 | $3.06 | 21,646 | $66K | 44.0% |
| 3 | $3.23 | 5,580 | $18K | 12.0% |
| Total | $3.08 avg | 48,872 | $150K | 100% |
| Filing → |
| ANIX | BUY | 2026-07-20 | $42K | — | Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |